NOVO Nordisk has filed lawsuits against two compounding pharmacies in Florida, US, who are allegedly offering contaminated copycat versions of semaglutide, the ingredient found in Ozempic and Wegovy.
Novo Nordisk said that it had conducted tests on the compounded products allegedly being sold as semaglutide from Wells Pharmacy and Brooksville Pharmaceuticals.
One sample from Wells Pharmacy allegedly had a level of unknown impurities of 33%, and samples from Brooksville Pharmaceuticals allegedly has lower levels of the active ingredient than described on the label, along with impurities, according to the lawsuits.
The lawsuits are a continuation of Novo Nordisk's legal battle with compounding pharmacies offering what they claim is semaglutide.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Dec 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Dec 23
